Logo

Guardant Health

Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug

The companies will jointly develop and commercialize Guardant360 CDx and Guardant360 TissueNext for taletrectinib treatment in advanced and metastatic NSCLC.

Guardant Health Nabs FDA Approval for Liquid Biopsy CDx With Menarini Breast Cancer Drug

The firm's liquid biopsy assay Guardant360 CDx can now be used to identify patients eligible for treatment with Menarini's Orserdu in ESR1-mutant breast cancer.

Guardant Health Lays off 7 Percent of Workforce

In a statement, Guardant Health cited the need to balance innovation with "financial discipline and focused execution" in the current economic environment.

Guardant Health, Royal Marsden Partner on Prospective Liquid Biopsy Trial in Early Colorectal Cancer

The study is evaluating the Guardant Reveal assay to guide chemotherapy treatment decisions following surgery for stage II to III colorectal cancer.

JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More

Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.

Jan 9, 2023

Guardant Health Preliminary Q4 Revenues Grow 15 Percent to 17 Percent

Jan 3, 2023

GenomeWeb Top 40 Down 3 Percent in December, Though More Resilient Than Broader Market

Dec 21, 2022

Guardant Health, Susan G. Komen Partner to Evaluate MRD Test in Breast Cancer

Dec 16, 2022

Guardant Health CRC Screening Results Spook Investors Despite Meeting Reimbursement Requirements

Dec 9, 2022

Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug

Nov 3, 2022

Guardant Health Sees Promising Q3 Uptake of Shield CRC Screening Test
Premium

Nov 1, 2022

Codex Genetics Inks Distribution Deal for Guardant Health Cancer Tests in Asia

Oct 19, 2022

Craig-Hallum Initiates Coverage of Guardant Health With Buy Rating

Oct 3, 2022

GenomeWeb Top 40 Declines 9 Percent in September, Marking Second Consecutive Down Month

Sep 11, 2022

Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients
Premium

Sep 2, 2022

In Brief This Week: Illumina, Interpace, Genetic Signatures, Guardant Health, More

Aug 12, 2022

Guardant Health, Thermo Fisher Scientific Tests Approved as CDx to Enhertu in Lung Cancer

Aug 5, 2022

Guardant Health Shares Details on MRD Reimbursement, Early Detection Trial
Premium

Aug 2, 2022

Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer

Jul 8, 2022

People in the News at New England Biolabs, Sema4, Guardant Health, More

Jul 6, 2022

Guardant Health Licenses Genomic Cancer Assays to Adicon for Testing in China

Jun 13, 2022

Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture

Jun 1, 2022

Omics Tools and MDx Stocks Trade Flat in May, Largely Tracking Broader Market

May 27, 2022

Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit

May 9, 2022

Guardant Health Confident in New CRC Screening Blood Test Despite Competitor Skepticism
Premium

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.